Drug Trial Radar · NCT06254612
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
497
Actual
Start
Mar 25, 2024
Primary completion
Jul 8, 2026
Study completion Jul 8, 2026
Sponsor
- Lead sponsor
- Sirtsei Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Rho, Inc.
- First posted
- Feb 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.
Conditions
- Major Depressive Disorder
Interventions
SP-624Drug
Once daily oral administration of two capsules totaling 20 mg/day
PlaceboDrug
Once daily oral administration of two matching placebo capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) total score.Time frame: Baseline to Week 4
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
IMA Clinical Research
Phoenix, Arizona
Noble Clinical Research
Tucson, Arizona
SanRo Clinical Research Group
Bryant, Arkansas
Clinical Innovations
Bellflower, California
Sun Valley Research Center
Imperial, California
Synergy San Diego
Lemon Grove, California
Excell Research
Oceanside, California
CiTrials
Riverside, California
Collaborative Neuroscience Research
Torrance, California
Sunwise Clinical Research
Walnut Creek, California
Next Level Clinical Trials
West Covina, California
MCB Clinical Research Centers
Colorado Springs, Colorado
Clinical Neuroscience Solutions
Jacksonville, Florida
Accel Clinical
Lakeland, Florida
Segal Trials
Lauderhill, Florida
Segal Trials - Miami Lakes
Miami Lakes, Florida
Clinical Neuroscience Solutions
Orlando, Florida
DMI Research
Pinellas Park, Florida
Accelerated Enrollment Solutions
Atlanta, Georgia
Velocity Clinical Research
Meridian, Idaho
Revive Research Institute
Elgin, Illinois
Tandem Clinical Research
Marrero, Louisiana
Boston Clinical Trials
Boston, Massachusetts
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan
Midwest Research Group
Saint Charles, Missouri
Alivation Research
Lincoln, Nebraska
IMA Clinical Research
Las Vegas, Nevada
Redbird Research
Las Vegas, Nevada
Center for Emotional Fitness
Cherry Hill, New Jersey
CenExel HRI
Marlton, New Jersey
IMA Clinical Research
Albuquerque, New Mexico
Integrative Clinical Trials
Brooklyn, New York
Pioneer Clinical Research
New York, New York
Magnolia Clinical Research
Cary, North Carolina
UNC Chapel Hill
Chapel Hill, North Carolina
New Hope Clinical Research
Charlotte, North Carolina
Velocity Clinical Research
Beachwood, Ohio
Midwest Clinical Research Center
Dayton, Ohio
North Star Medical Research
Middleburg Heights, Ohio
Summit Headlands
Portland, Oregon
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.